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Objective: To investigate the antibacterial activities of crude ethanol extracts of 12
Philippine medicinal plants.
Methods: Crude ethanol extracts from 12 Philippine medicinal plants were evaluated for
their antibacterial activity against methicillin-resistant Staphylococcus aureus,
vancomycin-resistant Enterococcus, extended spectrum b-lactamase-producing,
carbapenem-resistant Enterobacteriaceae and metallo-b-lactamase-producing Pseudo-
monas aeruginosa and Acinetobacter baumannii.
Results: The leaf extracts of Psidium guajava, Phyllanthus niruri, Ehretia microphylla
and Piper betle (P. betle) showed antibacterial activity against the Gram-positive meth-
icillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. P. betle
showed the highest antibacterial activity for these bacteria in the disk diffusion (16–
33 mm inhibition diameter), minimum inhibitory concentration (19–156 mg/mL) and
minimum bactericidal concentration (312 mg/mL) assays. P. betle leaf extracts only
showed remarkable antibacterial activity for all the Gram-negative multidrug-resistant
bacteria (extended spectrum b-lactamase-producing, carbapenem-resistant Enter-
obacteriaceae and metallo-b-lactamase-producing) in the disk diffusion (17–21 mm in-
hibition diameter), minimum inhibitory concentration (312–625 mg/mL) and minimum
bactericidal concentration (312–625 mg/mL) assays.
Conclusions: P. betle had the greatest potential value against both Gram-negative and
Gram-positive multidrug-resistant bacteria. Favorable antagonistic activities were also
exhibited by the ethanol extracts of Psidium guajava, Phyllanthus niruri and Ehretia
microphylla.1. Introduction
Antibiotic resistance is a problem that continues to challenge
the healthcare sector in a large part of the world in both devel-
oping and developed countries. The spread of multidrug-resistant (MDR) bacteria in hospital and community settings
remains a widely unresolved problem and a heavy burden to
health services [1]. Despite advances in antibiotic therapy,
infectious complications remain an important cause of
mortality and morbidity among hospitalized patients. Although
medical practitioners can resort to second- or third-choice
drugs for treating these patients, the use of these synthetic
drugs may subject the patient to a higher risk, due to the pos-
sibility of the drugs producing more harmful side effects. To
address this challenge, actions must be taken to reduce this
problem, such as controlling the use of antibiotics, understand-
ing the genetic mechanisms of resistance and developing newpen access article under the CC BY-NC-ND
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fying new sources of natural products with antimicrobial activ-
ities and expanding antibiotic chemical diversity are providing
chemical leads for new drugs [2].
The vast majority of modern medications were derived
originally from ancient herbal traditions. The practices of plant-
based traditional medicine are founded on hundreds of years of
belief and observations, which predate the development of
modern medicine. Medicinal plants have been used for centuries
as remedies for human diseases as they contain components of
therapeutic value. There are numerous plant natural products
which have antifungal, antibacterial and antiprotozoal activities
that could be used either systemically or locally [3]. Several
plants containing volatile oils, polyphenols and alkaloids as
active constituents are utilized as popular folk medicines,
while others gained popularity in the form of ﬁnished products
collectively named phytomedicines [4]. During the second half
of the 20th century, the acceptance of traditional medicine as
an alternative form of health care and the development of
microbial resistance to the classical antibiotics led researchers
to investigate the antimicrobial activities of medicinal plants.
Antimicrobials of plant origin have enormous therapeutic
potential [3]. They are effective in the treatment of infectious
diseases while simultaneously mitigating many of the side
effects that are often associated with synthetic antimicrobials.
Traditionally used medicinal plants produce a variety of
compounds of known therapeutic properties. One of the vital
activities possessed by these medicinal plants is antimicrobial.
The scarcity of infective diseases in plants is in itself an indi-
cation of the successful defense mechanisms developed by them
[5]. The substances that can either inhibit the growth of bacteria
or kill them, with no toxicity or minimum toxicity to host cells
are considered candidates for developing new antimicrobial
drugs [6]. Some of the bioactive compounds could hinder the
life processes of disease-causing bacteria, either by itself or in
combination with other therapeutic agents [7]. In recent years,
antimicrobial properties of medicinal plants are being
increasingly reported from different parts of the world [8–10]. It
is expected that plant extracts showing target sites other than
those used by antibiotics will be active against drug resistant
microbial pathogens. However, very little information is
available on such activity of medicinal plants [6]. There have
been numerous documentations found in the medical literature
concerning the signiﬁcance of traditional medicinal plants as
alternatives to synthetic antibacterial and antifungal
medications [11–17]. Most of these published works come from
many countries that are still practicing the use of herbal
medicine for the treatment of various diseases for practical and
economic reasons. These studies are valuable resources for
local medical scientists who seek to explore and substantiate
the antibacterial and antifungal activities of Philippine
medicinal herbs, particularly against MDR bacteria.
Knowledge on the different antimicrobial assays and the
plants’ bioactive compounds are vital for the design of future
studies [2].
The Philippines is one of the Asian countries with a diverse
ﬂora, and numerous species are believed to possess curative
properties. However, most of these claims lack scientiﬁc vali-
dation. The use of herbal medicines in the pre-Spanish era had
been widespread, although its documentation was only initiated
during the Spanish occupation, with the main practitioners being
called the mediquillos (herbal scientists) or herbolarios [18]. In1997, the Philippine Government passed Republic Act 8423,
also known as the “Traditional and Alternative Medicine Act
of 1997,” an act creating the Philippine Institute of Traditional
and Alternative Health Care to accelerate the development of
traditional and alternative health care in the Philippines [19].
Most noteworthy objectives include “the encouragement of
scientiﬁc research on traditional and alternative health care
systems that have direct impact on public health care, and the
promotion of the use of traditional, alternative, preventive and
curative health care modalities that have been proven safe,
effective, cost-effective, and they are consistent with govern-
ment standards on medical practice.”
The Infectious Disease Society of America has considered
the following bacteria as especially challenging in terms of
management: methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant Enterococcus (VRE), extended
spectrum b-lactamase (ESbL)-producing and carbapenem-
resistant Enterobacteriaceae (CRE), metallo-b-lactamase
(MbL)-producing Pseudomonas aeruginosa (P. aeruginosa) and
Acinetobacter baumannii (A. baumannii) [20]. In Asia, the same
emerging MDR bacteria have turned into an immense threat.
There have also been distressing reports regarding the
occurrence of ESbL-producing Enterobacteriaceae in fresh
imported culinary herbs from Thailand, Vietnam and
Malaysia, which are usually consumed without appropriate
heating [21]. Even A. baumannii, over the last 10 years, has
emerged as one of the most problematic bacteria since it
exhibits a wide spectrum of antimicrobial resistance
mechanisms, such that treatment has been limited to a few
antibiotics [22]. VRE likewise has emerged as one of the
difﬁcult-to-treat bacteria that cause several life-threatening in-
fections, and for which a deﬁnitive and successful therapy re-
mains elusive from the reach of an ever-growing number of
patients [23]. The advent of these MDR bacteria has solicited
some inquiries with regard to the future of therapeutic drugs
in chemotherapy. In line with the aforementioned ﬁndings, it
is crucial that therapeutic antimicrobial studies should be more
focused on the inhibition of these medically signiﬁcant
bacteria [24].
This study aimed to investigate the antibacterial activities of
crude ethanol extracts of 12 Philippine medicinal plants, namely,
Cassia alata L. (locally known as “akapulko”) (C. alata), Psi-
dium guajava L. (locally known as “bayabas”) (P. guajava),
Piper betle L. (locally known as “ikmo”) (P. betle), Vitex
negundo L. (locally known as “lagundi”) (V. negundo), Mitre-
phora lanotan (locally known as “lanotan”) (M. lanotan), Zin-
giber ofﬁcinale Rosc. (locally known as “luya”) (Z. ofﬁcinale),
Curcuma longa (locally known as “luyang dilaw”) (C. longa),
Tinospora rumphii Boerl (locally known as “makabuhay”)
(T. rumphii),Moringga oleifera (locally known as “malunggay”)
(M. oleifera), Phyllanthus niruri (locally known as “sampa-
sampalukan”) (P. niruri), Centella asiatica (locally known as
“takip kuhol”) (C. asiatica), and Ehretia microphylla Lam.
(locally known as “tsaang gubat”) (E. microphylla) against
different MDR bacteria isolated from a tertiary medical center in
the Philippines. Selection of the plants was based on their
documented medicinal values. All 12 plants have traditionally
known antibacterial and antifungal activities, with no extensive
bioassay studies performed locally. In order to identify the plants
with potential bioactive molecules of pharmaceutical importance
in the management of MDR bacteria, in vitro methods of eval-
uation on test organisms were performed using the plant extracts.
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2.1. Plant materials
The 12 medicinal plant samples tested in this study are shown
in Table 1. These were collected from different regions of the
Philippines. All the plant materials were identiﬁed and compared
to voucher specimens at the Herbarium of the Institute of
Biology, University of the Philippines Diliman for authentica-
tion. The different plant parts were washed with water to remove
all unwanted materials, air-dried, pulverized in a mill and stored
in a sterile air-tight container until further use.
2.2. Plant extract preparation
Plant extracts were prepared in accordance to the methods of
Basri and Fan with minor modiﬁcations [25]. Brieﬂy, 150 g of
each powdered plant material was soaked in 500 mL of
ethanol for 24 h with shaking. The resultant extracts were
centrifuged at 3000 r/min for 5 min at 4 C. The supernatant
was ﬁltered through Whatman ﬁlter paper No. 1 (Whatman,
UK), while the residues were used for a second extraction
with 300 mL of ethanol. After the second extraction, the
ﬁltrates were concentrated under reduced pressure using a
rotary evaporator at 50 C. The crude extracts were collected
and allowed to dry at room temperature.Table 1
Philippine medicinal plants assayed against different MDR bacteria.
Scientiﬁc name Family Local name
P. guajava Myrtaceae Bayabas
M. oleifera Moringaceae Malunggay
T. rumphii Menispermaceae Makabuhay
P. niruri Euphorbiaceae Sampa-sampaluk
C. asiatica Apiaceae Takip kuhol
P. betle Piperaceae Ikmo
C. longa Zingiberaceae Luyang dilaw
Z. ofﬁcinale Zingiberaceae Luya
V. negundo Verbenaceae Lagundi
M. lanotan Annonaceae Lanotan
E. microphylla Boraginaceae Tsaang gubat
C. alata Fabaceae Akapulko
Table 2
Panel of test organisms for primary antibacterial in vitro screening.
Characteristic Species
Gram-positive coccus S. aureus
Enterobacteriaceae E. coli
Enterobacteriaceae, encapsulated K. pneumoniae
Non-Enterobacteriaceae P. aeruginosa
Gram-positive coccus, MDR, #1 MRSA
Gram-positive coccus, MDR, #2 MRSA
Gram-positive coccus, MDR, #3 MRSA
Gram-positive coccus, MDR, #4 MRSA
Enterobacteriaceae, MDR ESbL, E. coli
Enterobacteriaceae, encapsulated, MDR ESbL, K. pneumoniae
Non-Enterobacteriaceae, MDR MbL, P. aeruginosa
Non-Enterobacteriaceae, MDR MbL, A. baumannii
Enterobacteriaceae, MDR CRE, E. coli
Enterobacteriaceae, encapsulated, MDR CRE, K. pneumoniae
VRE VRE
AM: ampicillin; FEP: cefepime; CTX: cefotaxime; FOX: cefoxitin; CTZ: ce
oxacillin; P: penicillin; VA: vancomycin; S. aureus: Staphylococcus aureus2.3. Test microorganisms
The panel of test organisms for primary in vitro antibacterial
screening in this study is summarized in Table 2. About 10
MDR bacteria were isolated from patients of the Makati Medical
Center, Makati City, Philippines. All isolates were identiﬁed by
automated biochemical tests using Vitek®MS (bioMe´rieux,
Marcy l'Etoile, France) Gram-positive colorimetric identiﬁcation
card. The susceptibility patterns were obtained using Vitek®MS
aspartate aminotransferase (bioMe´rieux, Marcy l’Etoile, France)
following minimum inhibitory concentration (MIC) interpretive
standards from the Clinical Laboratory Standard Institute M100-
S25 [26].
2.4. Antibacterial assay of plant extracts
The plant extracts were tested for antibacterial activity using
the disk diffusion method. The test organisms were subcultured
in 5% sheep blood agar plate (BAP) for 24 h at (35 ± 2) C. The
colonies were inoculated in normal saline solution. The turbidity
was then adjusted to equal the turbidity of 0.5 McFarland
standard giving a ﬁnal inoculum of 1.5 × 108 CFU/mL. About
100 mL of inoculum of test organism was spread on Mueller-
Hinton agar plate (Remel™, Thermo Fisher Scientiﬁc, USA).
Sterile 6 mm paper disks (Becton Dickinson and Company,
USA) with the plant extracts (200 mg) or solvent blank (dimethylPlant part used Place of collection
Leaves Tacloban, Leyte
Leaves Cainta, Rizal
Stem Tacloban, Leyte
an Aerial parts Tacloban, Leyte
Leaves Luisiana, Laguna
Leaves General Nakar, Quezon
Rhizome Luisiana, Laguna
Rhizome Luisiana, Laguna
Leaves Roxas, Palawan
Leaves Mt. Isarog, Camarines Sur
Leaves Tanay, Rizal
Leaves Angono, Rizal
Source Antibiotic resistance pattern
ATCC 29223 Susceptible
ATCC 25922 Susceptible
ATCC BAA-1705 Susceptible
ATCC 27853 Susceptible
12/Male, wound AM, FOX, OX, P
69/Male, wound AM, FOX, OX, P
42/Male, blood AM, FOX, OX, P
35/Female, sputum AM, FOX, OX, P
55/Female, blood AM, FEP, CTX, CTZ, CRO
25/Female, urine AM, FEP, CTX, CTZ, CRP
64/Male, blood FEP, CRZ, IPM, MEM
53/Female, blood FEP, CRZ, IPM, MEM
48/Male, urine AM, FEP, CTX, CTZ, CRO, IPM, MEM
58/Female, sputum AM, FEP, CTZ, CTZ, CRO, IPM, MEM
45/Male, urine P, VA
ftazidime; CRO: ceftriaxone; IPM: imipenem; MEM: meropenem; OX:
; E. coli: Escherichia coli; K. pneumoniae: Klebsiella pneumoniae.
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plates were incubated at (35 ± 2) C for 16–24 h. Represen-
tative antibiotics of the test isolates based on susceptibility
patterns were used as positive controls (Table 2). Antibacterial
activities were evaluated by measuring the diameters of zones
of inhibition in mm against the test organism.
2.5. Determination of MIC and minimum bactericidal
concentration (MBC) of the plant extracts
The MICs of the plant extracts were determined in sterile
96-well microplates using the broth microdilution method of
the Clinical and Laboratory Standards Institute, M07-A8 [26].
Each test was done in triplicate. The plant extracts were
serially diluted to produce ﬁnal concentrations of 19 mg/mL
to 10 000 mg/mL. Cation-adjusted Mueller-Hinton broth
(Becton Dickinson and Company, USA) was used as diluent.
The set-up included bacterial growth controls in wells con-
taining 10 mL of the test inoculum and negative controls
without bacterial inoculum. Reference drug controls were
likewise included in the set-up.
The inoculum was prepared by direct saline suspension of
isolated bacterial colonies selected from an 18–24 h 5% sheep
BAP culture. Suspension was adjusted to achieve a turbidity
equivalent to 0.5 McFarland turbidity standard, which
approximated 1.5 × 108 CFU/mL. Within 15 min after stan-
dardization, 10 mL of the adjusted inoculum was added into
each well containing 100 mL plant extract in the dilution
series, and mixed. The sealed microdilution trays were
incubated at (35 ± 2) C for 16–20 h in an ambient air
incubator.
The MIC was determined by selecting the lowest concen-
tration of plant extract that completely inhibited the growth of
the organism in the well as detected by the unaided eye. To
determine the growth end points, the amount of growth in the
wells containing the plant extracts was compared with the
amount of growth in the growth-control well (no plant ex-
tracts) used in each set of tests. For a test to be considered
valid, acceptable growth (2 mm button or deﬁnite turbidity)
must occur in the growth-control well.
The MBC was determined following the methods described
by Irobi and Daramola with slight modiﬁcations [27]. Wells
with no visible growth in MIC assays were subcultured
using a 10 mL inoculating loop onto a 5% sheep BAP at
(35 ± 2) C for 16–20 h incubation. The MBC was deﬁned
as the lowest concentration of the extract that did not permit
any growth.
3. Results
3.1. Disk diffusion method
The disk diffusion method for antimicrobial susceptibility
testing was initially performed to determine the antibacterial
activities of the 12 medicinal plants against MDR bacteria,
namely, MRSA, VRE, MbL P. aeruginosa and A. baumannii,
ESbL E. coli, ESbL K. pneumoniae and CRE K. pneumoniae.
ATCC control strains of S. aureus, E. coli, K. pneumoniae and
P. aeruginosa were also included. Of the 12 medicinal plants,
the ethanolic extracts of E. microphylla, P. niruri, P. guajava
and P. betle showed inhibition of bacterial growth against
some or all of the test organisms (Table 3). The plant extracts
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Demetrio L. Valle Jr. et al./Asian Pac J Trop Biomed 2015; 5(7): 532–540536exhibited inhibition zones ranging from 9 mm to 34 mm
diameter, with the most noteworthy results shown by P. betle
(Figure 1). Cefoxitin 30 mg disk (14 mm) showed a resistant
result. The diameters included the 6 mm ﬁlter paper disk.
The ethanolic extract prepared from the P. betle leaf
demonstrated inhibition zones greater than 15 mm in diameter,
as shown in Table 3, with the greatest zones (28–34 mm)
produced against the clinical strains of VRE and MRSA and
for the S. aureus ATCC control strain. The leaf extract like-
wise showed growth inhibition against all Gram-negative
clinical MDR bacterial strains and their respective ATCC
controls tested, with zones ranging from 16 mm to 23 mm. On
the other hand, P. guajava and P. niruri produced zones of
growth inhibition against both clinical MRSA and VRE and
ATCC strain of S. aureus, but failed to inhibit the growth of
Gram-negative organisms tested. E. microphylla likewise
exhibited inhibition zones for clinical strains of MRSA, VRE
and S. aureus ATCC 25923. In addition, it inhibited the Gram-
negative MbL A. baumannii and P. aeruginosa ATCC 27853.
Results of the disk diffusion assay showed that the most
commonly inhibited bacteria by the ethanolic plant extracts
were the clinical MRSA and VRE strains, and the ATCC
control S. aureus, followed by MbL A. baumannii and
P. aeruginosa ATCC 27853.
3.2. MIC
The MIC assay of the P. betle leaf extract consistently
showed strong antagonistic activities against all microorgan-
isms tested, with MIC values ranging from 19 to 1250 mg/mL
(Table 4). The strongest activity was exhibited against the
clinical strains of Gram-positive bacteria: VRE (19 mg/mL),
MRSA 4 (78 mg/mL), MRSA 1–3 (each with MIC of 156 mg/
mL) and S. aureus ATCC 25923 (312 mg/mL). For the Gram-
negative bacteria, the most common MIC value was 625 mg/
mL for MbL A. baumanni, ESbL K. pneumoniae, E. coli
ATCC 25922 and P. aeruginosa ATCC 27853, followed by
312 mg/mL for MbL P. aeruginosa, ESbL E. coli and CREFigure 1. Zones of inhibition of P. betle (32 mm), E. microphylla
(19 mm), V. negundo (0 mm) and M. lanotan (0 mm) against clinical
isolate MRSA 1. T
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showed MIC greater than 1000 mg/mL (1250 mg/mL).
P. guajava and P. niruri similarly showed good patterns of
inhibition against all Gram-positive bacteria tested, although
the MIC values were much higher than those for P. betle. The
MIC values ranged from 625 to 5000 mg/mL and 1250–
5000 mg/mL, respectively (Table 4). Similar to P. niruri, the
ethanol extract from E. microphylla showed MIC values of
1250–5000 mg/mL, with the lowest MICs for MRSA, VRE
and S. aureus ATCC 25923 and the highest MIC for MbL
A. baumannii.3.3. MBC
The MBCs were established by subculturing the samples
with no visible growth in the MIC assays. Most of the MBC
and MIC values for the ethanol plant extracts were closely
similar, with only P. niruri showing exactly identical values
for both assays (Table 5). Slightly higher MBC values for
MRSA 1 (312 mg/mL; MIC 156 mg/mL), ESbL E. coli
(625 mg/mL; MIC 312 mg/mL) and CRE K. pneumoniae
(625 mg/mL; MIC 312 mg/mL) were obtained with P. betle.
For P. guajava, the MBC values slightly differed for MRSA 1
(2500 mg/mL; MIC 250 mg/mL) and MRSA 2 (1250 mg/mL;
MIC 625 mg/mL) strains, whereas E. microphylla had slightly
higher MBC values for MRSA 2 (2500 mg/mL; MIC 1250 mg/
mL) and ATCC S. aureus control strain (2500 mg/mL; MIC
1250 mg/mL).4. Discussion
The current problem associated with emerging MDR bac-
teria presents a serious global medical crisis, requiring constant
surveillance, which continuously challenges the scientiﬁc
community [24]. The diminishing efﬁcacy and increasing
toxicity of synthetic drugs further aggravate this problem,
thus, scientists are directed to seek more natural or organic
materials for solutions. Traditional medicine has been
practiced worldwide for centuries, particularly the
application of herbal plants for therapeutic purposes.
Philippines possess a rich source of medicinal plants,
although not as extensive as India or China, enough to
provide us with alternative remedies [18]. The 12 plants have
been used locally for their traditional medicinal properties,
all of which have documented antimicrobial activities.
However, their efﬁcacies against MDR bacteria have not
been studied. In developing countries, it is imperative that
effective but less expensive antibacterials should be
developed to accommodate all patients, regardless of
ﬁnancial status, in order to eliminate some of the human
factors that can cause MDR.
In recent years, there are increasing published reports
showing successful antimicrobial activities of various tradi-
tional medicinal plants against MDR bacteria, such as MRSA,
ESbL, VRE, and MDR P. aeruginosa [9,28–38]. In the present
study, favorable antagonistic activities against various MDR
bacteria were exhibited by the ethanol extracts of four
Philippine medicinal plants, namely, P. betle, P. guajava,
P. niruri and E. microphylla.
As previously mentioned, the medicinal plants have known
antimicrobial properties, but their efﬁcacies against MDR
Demetrio L. Valle Jr. et al./Asian Pac J Trop Biomed 2015; 5(7): 532–540538bacteria have not been well-documented in the local medical
literature or in other countries. P. guajava has been separately
documented to be inhibitory against MRSA [39], MDR
V. cholera [40] and MDR S. aureus [41]. In relation to the
extraction method, it was reported that only ethanol extracts
showed antagonistic activities against Gram-negative bacteria
[10,42], while Mishra and Babele documented that the highest
antimicrobial activity was obtained with the methanol extract
of P. guajava leaf against drug resistant and susceptible
E. coli and P. aeruginosa [43]. In the present study, the
ethanol extract from the P. guajava leaf demonstrated
signiﬁcant inhibitory activities against MRSA and VRE and
no activity against the Gram-negative bacteria tested. MICs
and MBCs obtained in the current study are almost similar to the
values obtained from another study by Esimone against MRSA,
which ranged from 1250–5000 mg/mL for the water extracts, and
625–2500 mg/mL for the methanol extracts [39].
P. niruri is traditionally used for the treatment of kidney
stones, gallstones, wound healing, genito-urinary tract infections
and sexually transmitted diseases [18,44,45]. Bokarey
et al. determined that different extracts from the P. niruri
plant were effective against common human bacteria such as
S. aureus, E. coli, Proteus vulgaris and P. aeruginosa [46].
Our present study is the ﬁrst to show the antibacterial activity
of P. niruri against MRSA and VRE.
P. betle is a multifunctional medicinal plant, which is culti-
vated throughout the Philippines and can also be found in other
countries, such as Malaysia and India. The leaves have been
traditionally used to control caries, periodontal disease and
prevention of halitosis and is proven to have signiﬁcant
gastrointestinal and hepatoprotective effects [47,48]. The 80%
methanol and 70% ethanol leaf extracts have been reported to
be effective against strains of S. aureus, E. coli and
P. aeruginosa, with the methanolic extract exhibiting wider
zones of inhibition in the modiﬁed agar well diffusion method
by Khan and Kumar [49]. The zones of inhibition for the
methanolic extract ranged from 15 to 29.5 mm, whereas the
ethanol extracts showed inhibition zones ranging from 14 to
17 mm. MIC for both extracts ranged from 2 to 8196 mg/mL.
A similar study against the three bacteria has been performed
but with the addition of two extraction methods: cold aqueous
and ethyl acetate extracts of several Indian varieties of P. betle
leaves [50]. Another study showed the efﬁcacy of the ethanolic
leaf extract against K. pneumoniae and P. vulgaris, wherein
the MIC value obtained for the two bacteria was 25 mg/mL
[51]. In a more recent study related to the activities of 90%
methanol and 90% ethanol leaf extracts of P. betle against
clinical oral isolates (S. aureus, Staphylococcus epidermidis,
Bacillus cereus, Bacillus subtilis, Listeria monocytogenes,
E. coli, Salmonella typhimurium, Salmonella enteritidis,
K. pneumoniae and P. aeruginosa), the extracts demonstrated
good antimicrobial activities against the Gram-positive and
Gram-negative bacteria, except for P. aeruginosa [52]. At
present, studies on the antimicrobial activities of P. betle
against MRSA, ESbL, CRE, VRE, or MbL-producing
P. aeruginosa and A. baumannii have been noted in scientiﬁc
literature. The results of the present study showed that P. betle
had the greatest potential value against both Gram-negative
and Gram-positive MDR bacteria, exhibiting wide zones of
growth inhibition in the disk diffusion assay and with the lowest
concentrations of the extract required to inhibit the growth andaffect death of the pathogens, as supported by the MIC and
MBC assays, respectively.
E. microphylla, P. guajava and P. niruri also showed sig-
niﬁcant antagonistic activities against the Gram-positive bacte-
ria, but the limited or lack of activity against Gram-negative
bacteria has reduced their value as an ideal or broad spectrum
antibacterial for MDR microorganisms. Nevertheless, they can
still be developed as second or third choices for the treatment of
susceptible MDR bacteria. In addition, E. microphylla could
provide us with an alternative treatment for MbL-producing
A. baumannii and P. aeruginosa. In vitro antimicrobial studies
regarding E. microphylla are rarely encountered. It has been
surmised that the antibacterial activities of herbal plant extracts
and essential oils are focused on the structures and cellular
membranes and due to the presence of various bioactive com-
pounds and extensive chemical proﬁles, it is likely that the
antimicrobial potency is not just caused by one solitary mech-
anism but rather by several events at a cellular level [53].
The outer membrane found in the Gram-negative cell wall is
composed of structural lipopolysaccharides which render the cell
wall impermeable to lipophilic solutes, unlike Gram-positive
bacteria which do not have this outer membrane. This
morphologic difference inﬂuences their reaction to antibacterial
agents. In addition, Gram-negative bacteria also have inherent
overexpressed or multiple efﬂux pumps that prevent the intra-
cellular accumulation of antibacterial agents. Thus, there is a
need to discover and develop antibacterial agents that are
capable of bypassing or suppressing the efﬂux pumps and that
could also re-establish the antibacterial potency of older antibi-
otics [54]. Although previous studies on P. guajava [10,42] and
P. niruri [46] reported signiﬁcant antagonistic activities against
Gram-negative bacteria, the results of the present study did not
show the efﬁcacies of these two plants on the Gram-negative
bacteria tested. The variation in sensitivities could be attrib-
uted to the reinforced defense mechanisms acquired by the MDR
bacteria.
However, this study resolutely established the efﬁcacy of the
ethanolic leaf extract of P. betle against known Gram-positive
and Gram-negative MDR bacteria, indicating that the plant
produces compounds that are able to combat the bacterial de-
fenses. Henceforth, the results justify that further investigation
should be performed on P. betle. Additional or complementary
studies are necessary concerning the application of different
extraction methods, phytochemical screening, phytophysical
analysis, bioassay-guided isolation, puriﬁcation and quantiﬁca-
tion of the bioactive components, including the detection of
toxicity, side effects and pharmacokinetic properties in prepa-
ration for its in vivo assessment. Completion and favorable
outcomes obtained from succeeding studies would deﬁnitely
strengthen its potential as a novel and cost-effective agent
against MDR bacteria.
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